KANDERS WARREN B sold $6.5M of CDRE (indirect holdings)

KANDERS WARREN B (CEO AND CHAIRMAN) sold 225,000 indirectly-held shares of Cadre Holdings, Inc. (CDRE) at an average of $29.06 ($28.19–$30.03, $6.54M total) across 3 trades over 2026-06-15 to 2026-06-17.

Original reporting
SEC EDGAR · KANDERS WARREN B
Published Jun 17, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDRE
Neutral
medium confidence
Mentioned
$CDRE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDRENeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by the CEO/Chairman/10% owner totaling ~$6.54M across three trades at ~$28.19–$30.03.

02

Market read

Traders may treat the disclosure as a short-term sentiment input, but there is no new guidance, deal, or regulatory development in the text.

03

What to watch

The filing notes indirect holdings and no pre-arranged 10b5-1 plan; traders may over-weight the signal versus other insider activity and broader tape.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-17; disclosure window for insider-sale sentiment.

Background

This is an SEC Form 4 insider transaction disclosure for Cadre Holdings, Inc. (CDRE).

Company-level read

Ticker impact

$CDRENeutralMedium confidence
Context

Cadre Holdings CEO/Chairman Kanders sold $6.54M of CDRE shares in open-market trades (225,000 shares) disclosed via Form 4.

Expected impact

Likely modest negative/neutral bias for CDRE around the disclosure window; no clear directional signal beyond sentiment.

Evidence & confidence

The article is a primary-source Form 4 showing a multi-trade open-market sale by a top insider, but it provides no 10b5-1 plan details and no company-specific operational update.

Market effects

Limited read-across; insider-sale disclosures rarely change sector fundamentals absent accompanying guidance or regulatory events.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; without a stated reason or 10b5-1 plan, it may not reflect bearish fundamentals.

Key entities

  • Cadre Holdings, Inc.

    Subject of the Form 4 insider sale; CEO/Chairman/10% owner sold 225,000 shares for ~$6.54M.

  • KANDERS WARREN B

    CEO and Chairman; reported open-market sale of CDRE shares (indirect holdings) in June 2026.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDREMed

Cadre Holdings Inc (CDRE) (Q3 2026) Earnings Call Highlights: 30% Sales Surge, Raised

Cadre Holdings (CDRE) reported a 30% sales surge in Q3 2026 and raised guidance. CFO Blaine Browers emphasized M&A as a priority, with a $100M buyback program. Tier's revenue is tracking at $120M, and the company completed a small bolt-on acquisition. President Brad Williams discussed AI initiatives and political impacts on consumer demand. Tier's international business is a key growth driver, with margin expansion expected.

$CDREMed

Cadre Holdings (CDRE) Q3 2026 Earnings Call Transcript

Cadre Holdings (CDRE) reported Q3 2026 earnings with net income up 46% and adjusted EBITDA margin at 20.2%. The company raised 2026 guidance and announced a $100M stock buyback program. It also completed an acquisition to vertically integrate capabilities. Management highlighted strong demand drivers in public and nuclear safety markets and a robust M&A pipeline. Net sales were $203M, and adjusted EBITDA was $41M, both exceeding expectations.

$CDREHigh

Cadre’s (NYSE:CDRE) Q3 2026: strong sales

Cadre reported Q3 2026 revenue of $202.9M, beating estimates by 6.4% and growing 30.2% YoY. EPS and EBITDA also exceeded expectations. The company raised full-year revenue guidance to $762.5M and EBITDA guidance to $142M. Operating margin improved to 14%, while free cash flow margin declined to 9.8%.